Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 30 June, 2020

Credit Suisse (USA)

Form 38.5b - Aon plc

RNS Number : 5434R
Credit Suisse Securities (USA) LLC
30 June 2020
 

Ap27

 

 

FORM   38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

 Credit Suisse Securities (USA) LLC

Companydealtin

Aon plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

Ordinary

Date of dealing

29 June 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

14,084   0.006

1,252   0.001

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

14,084  0.006

1,252  0.001

             

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   2)

 

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 

 

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap28

 

 

3.  DEALINGS  (Note   3)

 

(a)  Purchases and sales

 

Purchase/sale

Numberofrelevantsecurities

Priceperunit ( USD)

B

279

188.22

B

279

188.22

B

4873

189.464

B

1194

190.02

B

1194

190.02

S

100

188.81

S

200

188.82

S

100

188.91

S

100

189.18

S

100

189.18

S

100

189.27

S

4873

189.464

S

100

189.51

S

92

189.58

S

50

189.61

S

34

189.61

S

16

189.61

S

100

189.62

S

100

189.74

S

2

189.79

S

1194

190.02

S

1194

190

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 5)

Numberofrelevantsecurities

(Note 6)

Priceperunit

(Note 4)

 

 

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 4)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 4)

 

 

 

 

 

(d)  Other   dealings   (including   transactions   in   respect   of   new   securities)   (Note   3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

Ap29

 

4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person

disclosing   and   any   other   person   relating   to   the   voting   rights   of   any   relevant   securities  

under   any   option   referred   to   on   this   form   or   relating   to   the   voting   rights  or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is 

referenced.   If   none,   this   should   be   stated.

 

Is a Supplemental Form 38.5(b) attached?  (Note   8)    NO

 

 

Dateofdisclosure

30-June-2020

 

Contactname

Anthony Allen / Paul MacDonald

Telephone number

0207 888 5416 / 8548

Name of offeree/offeror with which connected

Aon plc

Nature of connection (Note 9)

Advisor to Aon plc

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEFMMMTMTBJBLM

a d v e r t i s e m e n t